Clinical Trial

Pembrolizumab in Refractory Metastatic Anal Cancer

Complete title:
A Multicenter Phase 2 Clinical Trial of Pembrolizumab in Metastatic Anal Cancer
Trial phase:
Phase II
Study ID:
Local study ID:
This research study is studying a targeted therapy as a possible treatment for advanced anal cancer.
Trial keywords:
Anal Cancer
Enrollment status:
Trial eligibility
** For Eligibility information, please click on the "Look up trial at NIH" link above **
Other eligibility criteria may apply.
Trial exclusions
Other exclusion criteria may apply.
Learn more

Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each clinical trial.

Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.

Contact us
Seattle Cancer Care Alliance Intake Office
phone 1-800-606-7800